Forgot password
Enter the email address you used when you joined and we'll send you instructions to reset your password.
If you used Apple or Google to create your account, this process will create a password for your existing account.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Reset password instructions sent. If you have an account with us, you will receive an email within a few minutes.
Something went wrong. Try again or contact support if the problem persists.
Ubisoft recieves rating for a new game, Trials of the Blood Dragon, for Xbox One, PlayStation 4 and PC.

New Trials game trademark spotted on Taiwanese ratings board, and it’s a strange combination

Ubisoft recieves rating for a new game, Trials of the Blood Dragon, for Xbox One, PlayStation 4 and PC.
This article is over 8 years old and may contain outdated information

In what is a rather odd mash-up, it seems Ubisoft is planning to have the Trials franchise merge with Far Cry 3 spin-off Blood Dragon. It can only be described as an interesting fusion.

Recommended Videos

The news comes about as some eagle-eyed sleuths noticed a rating from the Taiwan Game Software Rating Regulations Board for a game called Trials of the Blood Dragon, which it seems will be coming to PC, PlayStation 4 and Xbox One.

It’s unclear if this will be a new entry in the Trials series, or if it will be a further expansion to Trials Fusion. That game has already received a batch of new content in the form of Trials Fusion: Awesome Level MAX, which featured a bunch of new levels and added items, as well as a gun-wielding, unicorn-riding cat.

This at least proves developer RedLynx has some experience when it comes to creating more out-there content, which will surely come in handy if the developer hopes to merge the franchise with the outlandish Far Cry 3: Blood Dragon.


GameSkinny is supported by our audience. When you purchase through links on our site, we may earn a small affiliate commission. Learn more about our Affiliate Policy
Author